Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125626011 | 12562601 | 1 | I | 20140502 | 20160715 | 20160715 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-20705109 | BRISTOL MYERS SQUIBB | 33.00 | YR | F | Y | 0.00000 | 20160715 | CN | AU | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125626011 | 12562601 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | INCREASED TO 15MG AFTER 5 DAYS | 21436 | 10 | MG | TABLET | QD | ||||||
| 125626011 | 12562601 | 2 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | INCREASED TO 30MG. | U | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125626011 | 12562601 | 1 | Product used for unknown indication |
| 125626011 | 12562601 | 2 | Depressive symptom |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125626011 | 12562601 | OT |
| 125626011 | 12562601 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125626011 | 12562601 | Psychotic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |